Healthcare Resource Utilisation of Severe Uncontrolled T2low and Non-T2low Asthma in Finland During 2018-2021

Autor: Persson J, Aakko J, Kaijala S, Lassenius MI, Viinanen A, Kankaanranta H, Lehtimäki L

Publikováno v: Journal of Asthma and Allergy, Vol Volume 17, Pp 681-691 (2024)

Josefine Persson,1 Juhani Aakko,2 Saara Kaijala,2 Mariann I Lassenius,2 Arja Viinanen,3 Hannu Kankaanranta,4 Lauri Lehtimäki5 1AstraZeneca, Nordic, Mölndal, Sweden; 2Medaffcon Oy, Espoo, Finland; 3Turku University Hospital, Division of Medicine, De

Externí odkaz: https://doaj.org/article/36537d5acf654dc19bf57c98a5f57a03

Type 2 Low Biomarker Stability and Exacerbations in Severe Uncontrolled Asthma.

Autor: Viinanen A; Division of Medicine, Department of Pulmonary Diseases, Turku University Hospital, 20014 Turku, Finland.; Department of Pulmonary Diseases and Clinical Allergology, University of Turku, 20014 Turku, Finland., Aakko J; Medaffcon Oy, 02130 Espoo, Finland., Lassenius MI; Medaffcon Oy, 02130 Espoo, Finland., Telg G; AstraZeneca, 51 85 Stockholm, Sweden., Nieminen K; AstraZeneca, 02150 Espoo, Finland., Kaijala S; Medaffcon Oy, 02130 Espoo, Finland., Lehtimäki L; Allergy Centre, Tampere University Hospital, Faculty of Medicine and Health Technology, Tampere University, 33014 Tampere, Finland., Kankaanranta H; Krefting Research Centre, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, 417 56 Gothenburg, Sweden.; Faculty of Medicine and Health Technology, Tampere University, 33014 Tampere, Finland.; Department of Respiratory Medicine, Seinäjoki Central Hospital, 60220 Seinäjoki, Finland.

Publikováno v: Biomolecules [Biomolecules] 2023 Jul 13; Vol. 13 (7). Date of Electronic Publication: 2023 Jul 13.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.